Search

Your search keyword '"Burns, Jane"' showing total 36 results
Start Over Author "Burns, Jane" Journal circulation
36 results on '"Burns, Jane"'

1. Letter by Daniels and Burns Regarding Article, “Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association Athletes

Author

Daniels, Lori B and Burns, Jane C

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Health Sciences, Clinical Sciences, Sports Science and Exercise, Athletic Injuries, Death, Sudden, Cardiac, Female, Humans, Male, Sports, Students, Cardiorespiratory Medicine and Haematology, Public Health and Health Services, Cardiovascular System & Hematology, Cardiovascular medicine and haematology, Clinical sciences, Sports science and exercise
Published
2016

2. Letter by Daniels et al Regarding Article, “Incidence, Causes, and Survival Trends From Cardiovascular-Related Sudden Cardiac Arrest in Children and Young Adults 0 to 35 Years of Age”

Author

Daniels, Lori B, Gordon, John B, and Burns, Jane C

Subjects
Good Health and Well Being, Arrhythmias, Cardiac, Coronary Artery Disease, Death, Sudden, Cardiac, Female, Heart Defects, Congenital, Humans, Male, Mortality, Cardiorespiratory Medicine and Haematology, Clinical Sciences, Public Health and Health Services, Cardiovascular System & Hematology
Published
2013

20. Abstract O.16: Comprehensive Genotyping Of The FCGR2/3 Locus Reveals A Novel Association Of FCGR2C-ORF With Susceptibility To Kawasaki Disease

Author

Kuijpers, Taco W, primary, Tacke, Carline E, additional, Nagelkerke, Sietse Q, additional, Breunis, Willemijn B, additional, Hoang, Long T, additional, Png, Eileen, additional, Geissler, Judy, additional, Tanck, Michael W, additional, Ellis, Justine A, additional, Ponsonby, Anne L, additional, Davila, Sonia, additional, Khor, Chiea C, additional, de Boer, Martin, additional, van der Heijden, Joris, additional, Fijnvandraat, Karin, additional, van der Schoot, E., additional, van den Berg, Timo K, additional, Yeung, Rae S, additional, Levin, Michael L, additional, Burgner, David, additional, Shimizu, Chisato, additional, Burns, Jane C, additional, and Hibberd, Martin L, additional

Published
2015
Full Text
View/download PDF

25. Abstract O.21: Inositol 1,4,5 triphosphate 3- kinase C regulates NLRP3 Inflammasome activation in Kawasaki disease

Author

Alphonse, Martin P, primary, Duong, Trang T, additional, Shimizu, Chisato, additional, Hoang, Long T, additional, McCrindle, Brian W, additional, Franco, Alessandra, additional, Schurmans, Stephane, additional, Philpott, Dana J, additional, Hibberd, Martin L, additional, Burns, Jane C, additional, Kuijpers, Taco W, additional, and Yeung, Rae S, additional

Published
2015
Full Text
View/download PDF

26. Abstract 4: Analysis of West Coast Atmospheric Circulation Patterns and Kawasaki Disease “Dry Spells”

Author

Burns, Jane C, primary, Tyree, Mary, additional, Berry, Erika K, additional, Rodó, Xavier, additional, Cayan, Daniel R, additional, Berger, Shaun S, additional, Bruce, Margaret, additional, Daru, Jennifer, additional, Everhart, Jennifer L, additional, Gilbert, Michael J, additional, Guzman-Cottrill, Judith, additional, Hindo, Heather, additional, Kosut, Jessica S, additional, Kurio, Gregory H, additional, Lee, Nathan C, additional, Mao, Chad Y, additional, Melish, Marian E, additional, Michalik, David E, additional, Pathare, Sameer, additional, Portman, Michael, additional, Schultz, Heather, additional, Trost, Margaret, additional, and Yee-Guardino, Stephanie A, additional

Published
2015
Full Text
View/download PDF

27. Abstract 189: Natural History of Coronary Artery Aneurysms in Kawasaki Disease in US population and Risk Factors for Persistent Aneurysms

Author

Friedman, Kevin G, primary, Hamaoko-Okamoto, Akiko, additional, Gauvreau, Kimberly, additional, de Ferranti, Sarah, additional, Baker, Annette, additional, Fulton, David, additional, Tremoulet, Adriana, additional, Tang, Alexander, additional, Berry, Erika, additional, Mahavadi, Vidya S, additional, Burns, Jane, additional, and Newburger, Jane, additional

Published
2015
Full Text
View/download PDF

29. Prevalence of Kawasaki Disease in Young Adults With Suspected Myocardial Ischemia

Author

Daniels, Lori B., primary, Tjajadi, Matthew S., additional, Walford, Hannah H., additional, Jimenez-Fernandez, Susan, additional, Trofimenko, Vera, additional, Fick, Daryl B., additional, Phan, Hoang-Anh L., additional, Linz, Peter E., additional, Nayak, Keshav, additional, Kahn, Andrew M., additional, Burns, Jane C., additional, and Gordon, John B., additional

Published
2012
Full Text
View/download PDF

31. Infective Endocarditis

Author

Baddour, Larry M., primary, Wilson, Walter R., additional, Bayer, Arnold S., additional, Fowler, Vance G., additional, Bolger, Ann F., additional, Levison, Matthew E., additional, Ferrieri, Patricia, additional, Gerber, Michael A., additional, Tani, Lloyd Y., additional, Gewitz, Michael H., additional, Tong, David C., additional, Steckelberg, James M., additional, Baltimore, Robert S., additional, Shulman, Stanford T., additional, Burns, Jane C., additional, Falace, Donald A., additional, Newburger, Jane W., additional, Pallasch, Thomas J., additional, Takahashi, Masato, additional, and Taubert, Kathryn A., additional

Published
2005
Full Text
View/download PDF

32. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease

Author

Newburger, Jane W., primary, Takahashi, Masato, additional, Gerber, Michael A., additional, Gewitz, Michael H., additional, Tani, Lloyd Y., additional, Burns, Jane C., additional, Shulman, Stanford T., additional, Bolger, Ann F., additional, Ferrieri, Patricia, additional, Baltimore, Robert S., additional, Wilson, Walter R., additional, Baddour, Larry M., additional, Levison, Matthew E., additional, Pallasch, Thomas J., additional, Falace, Donald A., additional, and Taubert, Kathryn A., additional

Published
2004
Full Text
View/download PDF

34. Lessons From a Kawasaki Mouse Model.

Author

Burns, Jane C.

Subjects
*MUCOCUTANEOUS lymph node syndrome, *HEART diseases, *JUVENILE diseases
Abstract

An introduction is presented in which the editor discusses an article within the issue related to the kawasaki disease (KD) which is the most common heart disease in children.

Published
2012
Full Text
View/download PDF

35. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Author

Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, and Durack DT

Subjects
American Heart Association, Anti-Bacterial Agents therapeutic use, Blood Flow Velocity, Endocarditis, Bacterial epidemiology, Endocarditis, Bacterial mortality, Endocarditis, Bacterial therapy, Humans, Quality Assurance, Health Care, Treatment Outcome, United States, Endocarditis, Bacterial prevention & control, Mucocutaneous Lymph Node Syndrome prevention & control, Rheumatic Fever prevention & control
Abstract

Background: The purpose of this statement is to update the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis that were last published in 1997., Methods and Results: A writing group was appointed by the AHA for their expertise in prevention and treatment of infective endocarditis, with liaison members representing the American Dental Association, the Infectious Diseases Society of America, and the American Academy of Pediatrics. The writing group reviewed input from national and international experts on infective endocarditis. The recommendations in this document reflect analyses of relevant literature regarding procedure-related bacteremia and infective endocarditis, in vitro susceptibility data of the most common microorganisms that cause infective endocarditis, results of prophylactic studies in animal models of experimental endocarditis, and retrospective and prospective studies of prevention of infective endocarditis. MEDLINE database searches from 1950 to 2006 were done for English-language papers using the following search terms: endocarditis, infective endocarditis, prophylaxis, prevention, antibiotic, antimicrobial, pathogens, organisms, dental, gastrointestinal, genitourinary, streptococcus, enterococcus, staphylococcus, respiratory, dental surgery, pathogenesis, vaccine, immunization, and bacteremia. The reference lists of the identified papers were also searched. We also searched the AHA online library. The American College of Cardiology/AHA classification of recommendations and levels of evidence for practice guidelines were used. The paper was subsequently reviewed by outside experts not affiliated with the writing group and by the AHA Science Advisory and Coordinating Committee., Conclusions: The major changes in the updated recommendations include the following: (1) The Committee concluded that only an extremely small number of cases of infective endocarditis might be prevented by antibiotic prophylaxis for dental procedures even if such prophylactic therapy were 100% effective. (2) Infective endocarditis prophylaxis for dental procedures is reasonable only for patients with underlying cardiac conditions associated with the highest risk of adverse outcome from infective endocarditis. (3) For patients with these underlying cardiac conditions, prophylaxis is reasonable for all dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa. (4) Prophylaxis is not recommended based solely on an increased lifetime risk of acquisition of infective endocarditis. (5) Administration of antibiotics solely to prevent endocarditis is not recommended for patients who undergo a genitourinary or gastrointestinal tract procedure. These changes are intended to define more clearly when infective endocarditis prophylaxis is or is not recommended and to provide more uniform and consistent global recommendations.

Published
2007
Full Text
View/download PDF

36. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Author

Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, and Taubert KA

Subjects
Ambulatory Care, American Heart Association, Anti-Infective Agents therapeutic use, Bacteria, Cardiovascular Diseases etiology, Cardiovascular Diseases microbiology, Disease Management, Echocardiography, Evidence-Based Medicine, Humans, Endocarditis, Bacterial complications, Endocarditis, Bacterial diagnosis, Endocarditis, Bacterial drug therapy
Abstract

Background: Despite advances in medical, surgical, and critical care interventions, infective endocarditis remains a disease that is associated with considerable morbidity and mortality. The continuing evolution of antimicrobial resistance among common pathogens that cause infective endocarditis creates additional therapeutic issues for physicians to manage in this potentially life-threatening illness., Methods and Results: This work represents the third iteration of an infective endocarditis "treatment" document developed by the American Heart Association under the auspices of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease of the Young. It updates recommendations for diagnosis, treatment, and management of complications of infective endocarditis. A multidisciplinary committee of experts drafted this document to assist physicians in the evolving care of patients with infective endocarditis in the new millennium. This extensive document is accompanied by an executive summary that covers the key points of the diagnosis, antimicrobial therapy, and management of infective endocarditis. For the first time, an evidence-based scoring system that is used by the American College of Cardiology and the American Heart Association was applied to treatment recommendations. Tables also have been included that provide input on the use of echocardiography during diagnosis and treatment of infective endocarditis, evaluation and treatment of culture-negative endocarditis, and short-term and long-term management of patients during and after completion of antimicrobial treatment. To assist physicians who care for children, pediatric dosing was added to each treatment regimen., Conclusions: The recommendations outlined in this update should assist physicians in all aspects of patient care in the diagnosis, medical and surgical treatment, and follow-up of infective endocarditis, as well as management of associated complications. Clinical variability and complexity in infective endocarditis, however, dictate that these guidelines be used to support and not supplant physician-directed decisions in individual patient management.

Published
2005
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results